Related Articles
Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)
Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro
Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review)
VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review) Corrigendum in /10.3892/ijo.2016.3636
Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (Review)